124 related articles for article (PubMed ID: 8210077)
1. The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardio-vascular disease.
Humphries SE
Ann Biol Clin (Paris); 1994; 52(1):67-75. PubMed ID: 8210077
[No Abstract] [Full Text] [Related]
2. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
Choluj B; Votruba T
Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
[TBL] [Abstract][Full Text] [Related]
3. [Molecular biology in the diagnosis of cardiovascular diseases].
Berg K
Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2370-4. PubMed ID: 9691807
[TBL] [Abstract][Full Text] [Related]
4. [Screening and treatment of children and adolescents with hypercholesterolemias and dyslipidemias].
Sobra J
Cas Lek Cesk; 1998 Feb; 137(3):67-72. PubMed ID: 9511274
[TBL] [Abstract][Full Text] [Related]
5. Familial combined hyperlipidaemia/polygenic mixed hyperlipidaemia.
Pedro-Botet J; Climent E; Gabarró N; Millán J
Clin Investig Arterioscler; 2021 May; 33 Suppl 2():43-49. PubMed ID: 34006353
[TBL] [Abstract][Full Text] [Related]
6. Endothelial function in familial combined hyperlipidaemia.
Ter Avest E; Holewijn S; van Tits LJ; de Wit HM; Stalenhoef AF; de Graaf J
Eur J Clin Invest; 2007 May; 37(5):381-9. PubMed ID: 17461984
[TBL] [Abstract][Full Text] [Related]
7. The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardiovascular disease. Committee on Molecular Biology Techniques in Clinical Chemistry of the International Federation of Clinical Chemistry (IFCC).
Humphries SE
J Int Fed Clin Chem; 1992 Dec; 4(5):208-18. PubMed ID: 10146701
[No Abstract] [Full Text] [Related]
8. [Xanthoma].
Shiraishi S
Ryoikibetsu Shokogun Shirizu; 1994; (4):203-5. PubMed ID: 8007132
[No Abstract] [Full Text] [Related]
9. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
[TBL] [Abstract][Full Text] [Related]
10. [Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia].
Steinmetz A; Schäfer JR
Wien Med Wochenschr; 1994; 144(12-13):299-307. PubMed ID: 8650933
[TBL] [Abstract][Full Text] [Related]
11. [The "second atherogenic phenotype" or the role of insulin resistance in vascular risk].
Ziegler O; Guerci B; Drouin P
Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():33-9. PubMed ID: 9833078
[TBL] [Abstract][Full Text] [Related]
12. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of familial hypercholesterolemia and of the dyslipidemias responsible for cardiovascular disease].
Sampietro T; Licitra R
G Ital Cardiol; 1999 Feb; 29(2):171-3. PubMed ID: 10088075
[No Abstract] [Full Text] [Related]
14. A testing time for heart disease.
George PM; Walmsley TA; Ikram H
N Z Med J; 1992 Jul; 105(937):258-60. PubMed ID: 1620510
[No Abstract] [Full Text] [Related]
15. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
16. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
[TBL] [Abstract][Full Text] [Related]
17. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
18. Genetic tests for familial hypercholesterolemia.
Day I; Humphries S
Nat Biotechnol; 1996 Oct; 14(10):1227-8. PubMed ID: 9631083
[No Abstract] [Full Text] [Related]
19. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia.
van Aalst-Cohen ES; Jansen AC; de Jongh S; de Sauvage Nolting PR; Kastelein JJ
Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431
[TBL] [Abstract][Full Text] [Related]
20. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
Koeijvoets KC; Mooijaart SP; Dallinga-Thie GM; Defesche JC; Steyerberg EW; Westendorp RG; Kastelein JJ; van Hagen PM; Sijbrands EJ
Eur Heart J; 2009 Mar; 30(5):618-23. PubMed ID: 19098018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
